Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in DSGN — Design Therapeutics, Inc.

CIK 902219 Boston, MA
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$280,718
-$265,544 QoQ
Shares Held
19,400
-86.3% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 136 holders
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 0% Shared 68% None 32%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. DSGN ranks #194 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in DSGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $280,718 19,400
2025-03-31 $546,262 141,519
2024-06-30 $859,700 256,627
2024-03-31 $863,668 214,310
2023-06-30 $3,164,961 502,375
2023-03-31 $3,175,415 550,332
2022-12-31 $7,620,511 742,740
2022-09-30 $15,863,483 948,773
2022-06-30 $14,821,086 1,058,649
2022-03-31 $16,136,642 999,173
2021-12-31 $18,317,068 855,538
2021-09-30 $14,037,586 955,588
2021-06-30 $18,683,908 939,362
2021-03-31 $34,145,350 1,141,985